Aisling Capital’s Ambit Biosciences Corp AMBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-1,650,156
Closed -$25.4M 21
2014
Q3
$25.4M Hold
1,650,156
4.93% 11
2014
Q2
$11.4M Buy
+1,650,156
New +$11.6M 3.3% 11

Aisling Capital's AMBI Position: Q4 2014 in Review

Aisling Capital sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 1,650,156 shares — an estimated $25.4M sold.

Aisling Capital first reported a position in AMBI in Q2 2014 and held it in 2 quarters. The position peaked at $25.4M in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

  • Aisling Capital reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
  • Aisling Capital sold 1,650,156 Ambit Biosciences Corp shares in Q4 2014, an estimated $25.4M.
  • Aisling Capital first reported a position in Ambit Biosciences Corp in Q2 2014 and held it in 2 quarters.
  • Aisling Capital's Ambit Biosciences Corp position peaked at $25.4M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Aisling Capital's 13F filing for Q4 2014, filed 13 Feb 2015.